Next-generation sequencing: an expedition from workstation to clinical applications

Abstract Next-generation sequencing (NGS) technologies have emerged as a powerful tool in the field of molecular biology and clinical applications. With the magnitude and efficiency of sequencing that can now be accomplished, NGS technologies have revolutionized the field of genomics and clinical diagnosis. The competence of NGS technologies has provided unprecedented opportunities to researchers to address an increasingly diverse range of biologic problems. Consistent efforts have been made by researchers and healthcare providers to translate the potential of NGS into clinical applications. Disease diagnostics, pathogen detection, and genetic mutations are some of the growing clinical areas where NGS is widely used. However, there are major challenges in translational bioinformatics that include storage and interpretation of complex datasets that require high computational power and requirement of well-trained professionals. Moreover, a combined effort between data analysts, geneticists, and physicians is required for the best NGS clinical applications. This chapter highlights the main aspects of NGS in clinical applications, recent advancements, and the significance of insights gained for future directions.

[1]  S. Kulkarni,et al.  Genetic variation in MKL2 and decreased downstream PCTAIRE1 expression in extreme, fatal primary human microcephaly , 2013, Clinical genetics.

[2]  T. Tan,et al.  Non‐invasive prenatal diagnostic testing for β‐thalassaemia using cell‐free fetal DNA and next generation sequencing , 2015, Prenatal diagnosis.

[3]  K. Hanson,et al.  Fatal Zika Virus Infection with Secondary Nonsexual Transmission. , 2016, The New England journal of medicine.

[4]  Claudia Giambartolomei,et al.  Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.

[5]  Y. Pawitan,et al.  Human genetics and genomics a decade after the release of the draft sequence of the human genome , 2011, Human Genomics.

[6]  S. An,et al.  Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen , 2019, International journal of molecular sciences.

[7]  Scar,et al.  Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.

[8]  John Y. K. Lee,et al.  Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas , 2014, Nature Genetics.

[9]  S. Eckhardt,et al.  Clinical Applications of Metabolomics in Oncology: A Review , 2009, Clinical Cancer Research.

[10]  Shuangling Chen,et al.  Human limbal niche cells are a powerful regenerative source for the prevention of limbal stem cell deficiency in a rabbit model , 2018, Scientific Reports.

[11]  Jan O. Korbel,et al.  Phenotypic impact of genomic structural variation: insights from and for human disease , 2013, Nature Reviews Genetics.

[12]  P. Knoepfler,et al.  Histone H3.3 mutations: a variant path to cancer. , 2013, Cancer cell.

[13]  J. Solassol,et al.  Circulating Cell Free Tumor DNA Detection as a Routine Tool for Lung Cancer Patient Management , 2017, International journal of molecular sciences.

[14]  Y. Ebenstein,et al.  Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH) , 2018, Nucleic acids research.

[15]  A. Ganesan,et al.  Multitarget Drugs: an Epigenetic Epiphany , 2016, ChemMedChem.

[16]  E. Weimer,et al.  Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing. , 2016, The Journal of molecular diagnostics : JMD.

[17]  P. Sham,et al.  The role of gene variants in the pathogenesis of neurodegenerative disorders as revealed by next generation sequencing studies: a review , 2017, Translational Neurodegeneration.

[18]  A. Barrett,et al.  Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach , 2015, Prenatal diagnosis.

[19]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[20]  Leming Shi,et al.  Next-generation sequencing in the clinic: promises and challenges. , 2013, Cancer letters.

[21]  M. Márquez,et al.  Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome , 2017, F1000Research.

[22]  M. Preul,et al.  MinION rapid sequencing: Review of potential applications in neurosurgery , 2018, Surgical neurology international.

[23]  David A. Matthews,et al.  Real-time, portable genome sequencing for Ebola surveillance , 2016, Nature.

[24]  Renu Vyas,et al.  Computational analysis of next generation sequencing data and its applications in clinical oncology , 2018 .

[25]  Razelle Kurzrock,et al.  Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative , 2012, Clinical Cancer Research.

[26]  Dag Harmsen,et al.  Bacterial Whole-Genome Sequencing Revisited: Portable, Scalable, and Standardized Analysis for Typing and Detection of Virulence and Antibiotic Resistance Genes , 2014, Journal of Clinical Microbiology.

[27]  Sebastian Schmeier,et al.  MinION Sequencing of colorectal cancer tumour microbiomes—A comparison with amplicon-based and RNA-Sequencing , 2020, PloS one.

[28]  Ryan L. Collins,et al.  Structural Chromosomal Rearrangements Require Nucleotide-Level Resolution: Lessons from Next-Generation Sequencing in Prenatal Diagnosis. , 2016, American journal of human genetics.

[29]  David Alland,et al.  Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes , 2013, Nature Genetics.

[30]  Peter A. Jones,et al.  Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.

[31]  Jerzy K. Kulski,et al.  In Phase HLA Genotyping by Next Generation Sequencing — A Comparison Between Two Massively Parallel Sequencing Bench-Top Systems, the Roche GS Junior and Ion Torrent PGM , 2014 .

[32]  B. Castellotti,et al.  A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability , 2018, Front. Mol. Neurosci..

[33]  Peter Donnelly,et al.  Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis , 2014, Human molecular genetics.

[34]  Maurizio Ferrari,et al.  Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities , 2018, EJIFCC.

[35]  Philip L. Tzou,et al.  Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing , 2018, Journal of Clinical Microbiology.

[36]  S. Morse,et al.  BacCapSeq: a Platform for Diagnosis and Characterization of Bacterial Infections , 2018, mBio.

[37]  Alessandro Romanel,et al.  Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care , 2016, npj Genomic Medicine.

[38]  Xifeng Wu,et al.  Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes , 2016, Oncotarget.

[39]  P. M. Williams,et al.  Clinical Applications of Next-Generation Sequencing in Precision Oncology , 2019, Cancer journal.

[40]  Jerzy K. Kulski,et al.  Next-Generation Sequencing — An Overview of the History, Tools, and “Omic” Applications , 2016 .

[41]  F. Alkuraya,et al.  Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation , 2012, Journal of Medical Genetics.

[42]  M. Leppert,et al.  Exome Analysis of a Family With Pleiotropic Congenital Heart Disease , 2012, Circulation. Cardiovascular genetics.

[43]  B. Thyagarajan,et al.  Review of Clinical Next-Generation Sequencing. , 2017, Archives of pathology & laboratory medicine.

[44]  J. Gibrat,et al.  Generations of Sequencing Technologies: From First to Next Generation , 2017 .

[45]  M. Swanson,et al.  RNA mis-splicing in disease , 2015, Nature Reviews Genetics.

[46]  Katherine Geiersbach,et al.  Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes. , 2010, Journal of biomolecular techniques : JBT.

[47]  L. Game,et al.  Target enrichment and high‐throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond‐Blackfan anaemia , 2013, British journal of haematology.

[48]  Rajesh Kumar Gazara,et al.  Comprehensive genome-wide analysis reveals different classes of enigmatic old yellow enzyme in fungi , 2014, Scientific Reports.

[49]  Andrew C. Wood,et al.  Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism , 2015, Nature.

[50]  Kathrin Lang,et al.  Full-Length HLA Class I Genotyping with the MinION Nanopore Sequencer. , 2018, Methods in molecular biology.

[51]  D. Goldstein,et al.  Mosaic mutations in early-onset genetic diseases , 2015, Genetics in Medicine.

[52]  W. Wasserman,et al.  Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype , 2014, Clinical genetics.

[53]  Matthew W. Anderson,et al.  Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing , 2013, Journal of Clinical Microbiology.

[54]  M. Esteller,et al.  Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.

[55]  Michael D. Wilson,et al.  Five-Vertebrate ChIP-seq Reveals the Evolutionary Dynamics of Transcription Factor Binding , 2010, Science.

[56]  A. Friedrich,et al.  Characterization of a CTX-M-15 Producing Klebsiella Pneumoniae Outbreak Strain Assigned to a Novel Sequence Type (1427) , 2015, Front. Microbiol..

[57]  Khalid Raza,et al.  Recent advancement in next-generation sequencing techniques and its computational analysis , 2016, Int. J. Bioinform. Res. Appl..

[58]  Ken Chen,et al.  Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. , 2011, JAMA.

[59]  Euan A Ashley,et al.  Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.

[60]  Joonhong Park,et al.  Considerations when using next-generation sequencing for genetic diagnosis of long-QT syndrome in the clinical testing laboratory. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[61]  D. Schübeler,et al.  Determinants and dynamics of genome accessibility , 2011, Nature Reviews Genetics.

[62]  Janet Kelso,et al.  High‐throughput sequencing of the melanoma genome , 2013, Experimental dermatology.

[63]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[64]  Peter Kraft,et al.  Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development , 2014, Nature Medicine.

[65]  Dahui Qin Next-generation sequencing and its clinical application , 2019, Cancer biology & medicine.

[66]  Michael Dean,et al.  A frame-shift mutation in the cystic fibrosis gene , 1990, Nature.

[67]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[68]  Nardin Samuel,et al.  Translating genomics to the clinic: implications of cancer heterogeneity. , 2013, Clinical chemistry.

[69]  V. Chini Micro-RNAs and next generation sequencing: new perspectives in heart failure. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[70]  Rajesh Kumar Gazara,et al.  Expansion and diversification of the gibberellin receptor GIBBERELLIN INSENSITIVE DWARF1 (GID1) family in land plants , 2017, Plant Molecular Biology.

[71]  C. Chiu Viral pathogen discovery , 2013, Current Opinion in Microbiology.

[72]  C. Cantor,et al.  Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[73]  Saumya Shekhar Jamuar,et al.  Clinical application of next-generation sequencing for Mendelian diseases , 2015, Human Genomics.

[74]  Tyler A. Land,et al.  Clinical Next Generation Sequencing Outperforms Standard Microbiological Culture for Characterizing Polymicrobial Samples. , 2016, Clinical chemistry.

[75]  N. Rosenfeld,et al.  Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA , 2013, Nature.

[76]  L. Müllauer Next generation sequencing: clinical applications in solid tumours , 2017, memo - Magazine of European Medical Oncology.

[77]  Yi-wu Shi,et al.  Epilepsy-associated genes , 2017, Seizure.

[78]  S. Lippman,et al.  Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience , 2016, Molecular Cancer Therapeutics.

[79]  Peiyong Jiang,et al.  Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics , 2017, Proceedings of the National Academy of Sciences.

[80]  Benjamin J. Wright,et al.  Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease , 2009, Nature Genetics.

[81]  Lora J. H. Bean,et al.  A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield , 2015, Annals of neurology.

[82]  Catherine Marcucci,et al.  The American Rare Donor Program. , 2013, Journal of critical care.

[83]  C. Semsarian,et al.  Key role of the molecular autopsy in sudden unexpected death. , 2012, Heart rhythm.

[84]  U. Jensen,et al.  Targeted gene sequencing and whole‐exome sequencing in autopsied fetuses with prenatally diagnosed kidney anomalies , 2018, Clinical genetics.

[85]  M. Kris,et al.  Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience. , 2016 .

[86]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[87]  Joel N Hirschhorn,et al.  Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation , 2010, Nature Genetics.

[88]  Richard M Leggett,et al.  MinION Analysis and Reference Consortium: Phase 2 data release and analysis of R9.0 chemistry , 2017, F1000Research.

[89]  R. Friedl,et al.  Whole Exome Sequencing Reveals Uncommon Mutations in the Recently Identified Fanconi Anemia Gene SLX4/FANCP , 2013, Human mutation.

[90]  Carl Virtanen,et al.  Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial , 2016, Genome Medicine.

[91]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[92]  Z. Weng,et al.  Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. , 2012, Archives of general psychiatry.

[93]  Daniel J. Gaffney,et al.  A survey of best practices for RNA-seq data analysis , 2016, Genome Biology.

[94]  Marc Gewillig,et al.  Rare variants in NR2F2 cause congenital heart defects in humans. , 2014, American journal of human genetics.

[95]  AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.

[96]  Christian Brueffer,et al.  Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative , 2018, JCO precision oncology.

[97]  G. Batist,et al.  Making Sense of Intratumor Genetic Heterogeneity: Altered Frequency of Androgen Receptor CAG Repeat Length Variants in Breast Cancer Tissues , 2013, Human mutation.

[98]  A. Munnich,et al.  KIF7 mutations cause fetal hydrolethalus and acrocallosal syndromes , 2011, Nature Genetics.

[99]  Petros Dellaportas,et al.  A Bayesian Approach for Analysis of Whole-Genome Bisulfite Sequencing Data Identifies Disease-Associated Changes in DNA Methylation , 2017, Genetics.

[100]  R. Rosch,et al.  Incorporating epilepsy genetics into clinical practice: a 360°evaluation , 2018, npj Genomic Medicine.

[101]  Henrik Hager,et al.  Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma , 2017, Oncotarget.

[102]  D. Fürst,et al.  Next-Generation Sequencing Technologies in Blood Group Typing , 2019, Transfusion Medicine and Hemotherapy.

[103]  L. Varuzza,et al.  RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. , 2017, Blood cells, molecules & diseases.

[104]  Khalid Raza,et al.  Machine Learning-based state-of-the-art methods for the classification of RNA-Seq data , 2017, bioRxiv.

[105]  N. Vora,et al.  Promises, pitfalls and practicalities of prenatal whole exome sequencing , 2018, Prenatal diagnosis.

[106]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Khalid Raza,et al.  Raw Sequence to Target Gene Prediction: An Integrated Inference Pipeline for ChIP-Seq and RNA-Seq Datasets , 2018, Advances in Intelligent Systems and Computing.

[108]  M. Brown,et al.  Short-rib polydactyly and Jeune syndromes are caused by mutations in WDR60. , 2013, American journal of human genetics.

[109]  E. Gibney,et al.  Epigenetics and gene expression , 2010, Heredity.

[110]  Lawrence O. Gostin,et al.  The Value and Importance of Health Information Privacy , 2009 .

[111]  Benedict Paten,et al.  Improved data analysis for the MinION nanopore sequencer , 2015, Nature Methods.

[112]  J. McPherson,et al.  Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.

[113]  Oliver G. Pybus,et al.  Mobile real-time surveillance of Zika virus in Brazil , 2016, Genome Medicine.

[114]  L. Anelli,et al.  Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities , 2020, Frontiers in Genetics.

[115]  Sylvie Cloutier,et al.  SNP Discovery through Next-Generation Sequencing and Its Applications , 2012, International journal of plant genomics.

[116]  Derick R. Peterson,et al.  Plasma phospholipids identify antecedent memory impairment in older adults , 2014, Nature Medicine.

[117]  M. Wicha,et al.  Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line. , 2017, Journal of proteome research.

[118]  Barry Merriman,et al.  Progress in Ion Torrent semiconductor chip based sequencing , 2012, Electrophoresis.

[119]  Andrea D. Tyler,et al.  Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications , 2018, Scientific Reports.

[120]  M. Mahajan,et al.  Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing , 2012, Movement disorders : official journal of the Movement Disorder Society.

[121]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[122]  Paola Sebastiani,et al.  Severe sickle cell anemia is associated with increased plasma levels of TNF‐R1 and VCAM‐1 , 2011, American journal of hematology.

[123]  Chee Seng Chan,et al.  CTCF-Mediated Functional Chromatin Interactome in Pluripotent Cells , 2011, Nature Genetics.

[124]  J. Garcia-conde,et al.  Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups , 2010, Leukemia.

[125]  Rajesh Kumar Gazara,et al.  Transcriptional landscape of soybean (Glycine max) embryonic axes during germination in the presence of paclobutrazol, a gibberellin biosynthesis inhibitor , 2018, Scientific Reports.

[126]  M. Sánchez Cánovas,et al.  Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables , 2019, Scientific Reports.

[127]  D. Frishman,et al.  Genetic Spectrum of Idiopathic Restrictive Cardiomyopathy Uncovered by Next-Generation Sequencing , 2016, PloS one.

[128]  W. Lipkin,et al.  Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis , 2015, mBio.

[129]  M. Loh,et al.  Philadelphia chromosome-like acute lymphoblastic leukemia. , 2017, Blood.

[130]  K. Kristiansen,et al.  Targeted next-generation sequencing as a comprehensive test for Mendelian diseases: a cohort diagnostic study , 2018, Scientific Reports.

[131]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[132]  Anne Floquet,et al.  Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. , 2017, The Lancet. Oncology.

[133]  Samatha Gunapati,et al.  Corrigendum: Expression of GhNAC2 from G. herbaceum, improves root growth and imparts tolerance to drought in transgenic cotton and Arabidopsis , 2016, Scientific Reports.

[134]  Xi-wu Zhang,et al.  Mass spectrometry-based metabolomics in health and medical science: a systematic review , 2020, RSC advances.

[135]  K. V. van Kessel,et al.  Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria. , 2016, The Journal of urology.

[136]  J. Lupski,et al.  Mutations in VRK1 associated with complex motor and sensory axonal neuropathy plus microcephaly. , 2013, JAMA neurology.

[137]  S. Turner,et al.  Real-Time DNA Sequencing from Single Polymerase Molecules , 2009, Science.

[138]  S. Drury,et al.  Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis , 2015, Prenatal diagnosis.

[139]  Rajesh Kumar Gazara,et al.  Draft genome sequencing and secretome analysis of fungal phytopathogen Ascochyta rabiei provides insight into the necrotrophic effector repertoire , 2016, Scientific Reports.

[140]  S. Bose,et al.  Proteomics Tools – An Update , 2017 .

[141]  Wei Gu,et al.  Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection. , 2019, Annual Review of Pathology.

[142]  Pranita D. Tamma,et al.  Applying Rapid Whole-Genome Sequencing To Predict Phenotypic Antimicrobial Susceptibility Testing Results among Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates , 2018, Antimicrobial Agents and Chemotherapy.

[143]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[144]  A. Sivachenko,et al.  A Landscape of Driver Mutations in Melanoma , 2012, Cell.

[145]  David S. Wishart,et al.  HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..

[146]  Benjamin A. Logsdon,et al.  Imputation of exome sequence variants into population- based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project. , 2012, American journal of human genetics.

[147]  L. Mestroni,et al.  Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[148]  Kristin R Brogaard,et al.  A base pair resolution map of nucleosome positions in yeast , 2012, Nature.

[149]  Matthew W. Snyder,et al.  Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin , 2016, Cell.

[150]  Anneleen Daemen,et al.  Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors , 2015, Proceedings of the National Academy of Sciences.

[151]  C. Férec,et al.  Next‐generation sequencing is a credible strategy for blood group genotyping , 2014, British journal of haematology.